← Human Trials & Peer-Reviewed Studies

Growth and Growth Hormone through the Ages: Art and Science.

Plain-language guide to PMID 36446319 (2022): review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Key Facts

PMID
36446319
Journal
Hormone research in paediatrics
Year
2022
Study type
Review
Authors
Rogol AD et al. (2 authors)
DOI
10.1159/000526440

What This Paper Covers, in Plain Language

What It Covers

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a review.

People have long been fascinated with the size and growth of living things, from the giants of classic mythology and art to the little people who also have appeared in classical art, as well as the courts of European monarchs, and were exploited in "shows." Serious medical evaluation began in the late 19th century with the description of acromegaly and its association with pituitary tumors.

In the early 20th century, multiple investigators attempted to extract a growth-promoting factor from the anterior pituitary and then, over the decades, to purify it and distinguish it from other anterior pituitary hormones.

What Was Measured

People have long been fascinated with the size and growth of living things, from the giants of classic mythology and art to the little people who also have appeared in classical art, as well as the courts of European monarchs, and were exploited in "shows." Serious medical evaluation began in the late 19th century with the description of acromegaly and its association with pituitary tumors.

PubMed files the paper under topics including Acromegaly, Dwarfism, Endocrine System Diseases, Growth Hormone, Human Growth Hormone and Pituitary Hormones, Anterior.

Author keywords: Bioassay, Hypopituitarism and Immunoassay.

What This Means in Plain Language

This is a review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 2022 (Hormone research in paediatrics), a journal based in Switzerland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.